JavaScript is disabled. Please enable to continue!

Mobile search icon
Regulatory Science Services >> Customer Segments >> Pharmaceuticals

Pharmaceutical Services

Sidebar Image

Eurofins Regulatory Science Services’ scientific experts have worked with virtually every class and type of compound, across most indications and all common formulations of pharmaceuticals. We have contributed data to and drafted sections of IND, NDA and ANDA submissions for dozens of commercial products. And we’ve helped hundreds of companies like yours overcome R&D roadblocks, respond to regulators and uncover sources of problematic manufacturing issues. From GLP and cGMP studies to contaminant and packaging investigations, together with the Eurofins Scientific Network, Eurofins Regulatory Science Services is able to support every phase of the product lifecycle.

ERA for Pharmaceuticals

In conducting Environmental Risk Assessments for pharmaceuticals, evaluating a pharmaceutical’s potential environmental impact requires expertise in both drug development and environmental testing. Eurofins Regulatory Science Services’ environmental risk assessment capabilities for human and veterinary pharmaceuticals provide the environmental data and guidance you need to meet testing and timing requirements. As partners with pharmaceutical and animal health companies, Eurofins also has a long history of supporting drug development through a deep understanding of global regulatory requirements for environmental submissions and can guide you through the assessment process with accurate timelines.

Veterinary Drugs

Over our more than two decades’ experience with drug chemistries, Eurofins Regulatory Science Services has worked with virtually every type of veterinary medicine and feed additive for livestock and companion animals. We provide NADA-and INAD-enabling, registration, and post-commercialization support and lifecycle management of veterinary medicines, pesticides, parasiticides, and other therapies, including biologics. Our scientists have helped many companies like yours answer challenging development questions, respond to regulators and uncover sources of problematic manufacturing issues regarding veterinary drugs.

Contact erssinfo@eurofins.com for more information!